Suchergebnisse - "Itolizumab"

PubPharm (65)

51

Immunological evaluation of rheumatoid arthritis patients treated with itolizumab

enthalten in: mAbs | 2016

von Aira, L. | Hernández, P. | Prada, D. | +6

52

Therapeutic Targeting of CD6 in Autoimmune Diseases : A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab

enthalten in: Current drug targets | 2016

von Hernández, P. | Moreno, E. | Aira, L. | +1

53

Safety and Efficacy of Itolizumab in the Treatment of Psoriasis: A Case Series of 20 Patients

in: Journal of Clinical and Diagnostic Research | 2016

von Anchala Parthasaradhi

54

Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis : A double-blind, randomized-withdrawal, placebo-controlled study

enthalten in: Journal of the American Academy of Dermatology | 2015

von Dogra, S. | D S, K. | Budamakuntla, L. | +20

55

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2015

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

56

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2015

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

57

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2015

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

58

Itolizumab provides sustained remission in plaque psoriasis : a 5-year follow-up experience

enthalten in: Clinical and experimental dermatology | 2015

von Budamakuntla, L. | Madaiah, M. | Sarvajnamurthy, S. | +1

59

Itolizumab - a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis

enthalten in: Clinical, cosmetic and investigational dermatology | 2015

von Menon, R. | David, B.

ErratumIn: Clin Cosmet Investig Dermatol. 2015;8:295. - PMID 26082656

60

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis : results of a double-blind, randomized, placebo-controlled, phase-III study

enthalten in: Journal of the American Academy of Dermatology | 2014

von Krupashankar, D. | Dogra, S. | Kura, M. | +21